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SummARy – Chronic superior mesentery ischemia often presents a clinically asymptomatic 
diffuse atherosclerotic process. There are no compelling recommendations on the benefits of early re-
vascularization strategy besides antithrombotic prophylaxis and statin treatment. Conversely, long-
term prevalence of symptomatic cases in surgical patient cohorts is rarely reported in the literature. 
Acutization of chronic ischemia has a severe clinical course, so timely recognition may be considered 
lifesaving. We present a case of an 86-year-old woman hospitalized for acutized atherosclerotic 
narrowing of superior mesenteric artery. The patient was urgently operated on by aorto-mesenteric 
ring prosthesis revascularization. postoperative course was uneventful and the patient regained 10 
kilograms in the next few months.
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Introduction
mesenteric ischemia occurs from insufficient cir-
culation supply over the arterial or venous beds. Acute 
form follows occlusive changes, embolism or vasos-
pasm in the arterial circulation. Venous thrombosis 
or strangulation is likewise responsible part of acute 
presentations. Chronic mesenteric ischemia or “ab-
dominal angina” represents relapse-remitting or con-
stant chronic intestinal hypoperfusion, mostly due to 
advanced atherosclerotic process. Symptomatic phase 
of intestinal angina includes emblematic postprandial 
cramps or dull abdominal pain, usually one hour af-
ter eating and persisting for up to two hours1. Acute-
on-chronic ischemia is a life threatening condition, in 
contrast to interventional treatment of chronic symp-
tomatic episodes of steady angina1. Consequently, 
proper thought of diagnosis, mandatory early rec-
ognizing and timely treatment represent life-saving 
emergency. earlier interventions offered improvement 
in survival and quality of life, resembling the short 
door-to-balloon benefits of percutaneous coronary in-
terventions2.
Case Report
An 86-old-woman with diabetes was hospital-
ized through emergency department due to acute se-
vere abdominal pain, general worsening with dehy-
dration, nonketotic hypoglycemia and hypotension, 
after more than 6 months of progressive weakening 
and significant weight loss of 25 kilograms associ-
ated with chronic abdominal pain. medical records 
showed hypothyroidism, well regulated hypertension, 
atrial fibrillation, valvular heart disease with dilated 
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ventricles and diastolic dysfunction. Routine labora-
tory tests were non diagnostic, fecal occult blood test 
was negative, and so were oncology serum cancer 
antigens. There were no signs of proliferative disor-
ders on endoscopies or transabdominal ultrasound. 
Contrast enhanced multidetector row computerized 
tomography showed atherosclerotic narrowing of the 
celiac trunk and superior mesenteric artery (fig. 1). 
Culprit lesion was inappropriate for percutaneous 
dilatation and stenting due to convoluted morphol-
ogy and calcifications, thus the patient was urgently 
operated on by aorto-mesenteric revascularization us-
ing ring prosthesis. During hospital stay, the patient 
received total parenteral nutrition and probiotics, i.e. 
enteral substitution in the early postoperative course. 
postoperative follow up was free from complications 
and the patient was subjectively well, capable of usual 
daily vocational activities and regained 10 kilograms 
in the next months.
Discussion
Acute mesenteric ischemia usually manifests with 
sudden over proportionate pain intensity for a few of 
clinical status changes. nausea, vomiting and forceful 
stool evacuation are common accompanying symp-
toms. mesenteric thrombosis, on the other hand, 
has subacute manifestations, with a more prolonged 
symptomatic course lasting up to couple of weeks. 
more severe pain is generally related to occlusion of 
the superior mesenteric artery supplying small bowel 
and right sided colon, while the remainder colonic 
ischemia has milder manifestations. Development of 
transmural bowel infarction set grounds for peritoneal 
irritation and inflammation, distension of the abdo-
men and quiescent bowel sounds on auscultation. The 
pathoanatomic substrates of abdominal ischemia are 
archetypal and include acute mesenteric embolism, 
acute mesenteric artery thrombosis, venous mesen-
teric thrombosis and non-occlusive ischemia3,4. pa-
tients of younger age are frequently prone to embolic 
events rather than metabolic syndrome complications 
and atherosclerosis related comorbidities occurring in 
more advanced age5. 
in order to alter the poor natural course of acute 
mesenteric ischemia, it is of utmost importance to es-
tablish the diagnosis prior to the development of in-
testinal infarction. laboratory tests are generally non 
diagnostic, representing a set of unspecific metabolic 
changes. exception in laboratory diagnosis is negative 
predictive value of the low D-dimer test ruling out 
mesenteric ischemia. Digital angiography is the gold 
standard in the diagnosis and/or interventions with 
documented ameliorative overall survival changes in 
the last two decades6. Wide availability of angiog-
raphy has shown clear benefits of early interventions 
with nearly 70% survival rates within 12-hours of 
event versus 70% mortality in the pre-angiography 
era7. Continuous infusion of vasodilators, papaverine 
could be applied for up to 5 days in occlusive or non-
occlusive cases8. Surgical embolectomy of arterial em-
bolus in clinical instance could be followed by re-lapa-
rotomy, i.e. “second look” in 24-48 hours for resection 
of the gangrenous tissue. Warfarin therapy combined 
with clopidogrel was found to have a synergistic effect 
for prevention of re-embolization events9. Atheroscle-
Fig. 1. Superior mesenteric artery atherosclerotic occlusion – multidetector row contrast enhanced computerized tomogra-
phy: (A) superior mesenteric artery; (B) magnified superior mesenteric artery; (C) celiac trunk.
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rotic mesenteric artery thrombosis is best managed 
with revascularization, either surgical or percutaneous 
with stent implantation10. The “two-vessel” revascu-
larization approach was developed in order to attain 
better control of symptoms, which de facto increased 
the prevalence of combined chronic comorbidities in 
the population and more complicated atherosclerotic 
lesions, the most commonly outspread beyond single 
vessel disease11. The management of acute mesenteric 
venous thrombosis includes anticoagulation therapy 
and operative resection of gangrenous tissue. Recently, 
multi-row detector computerized contrast enhanced 
tomography (mDCt) and magnetic resonance an-
giography (mRA) have become very important diag-
nostic tools with overall accuracy of over 95%, wide 
availability, and improvement in survival rates12. 
on the other hand, the diagnosis of chronic mes-
enteric ischemia is a more challenging issue, since a 
great deal of angiography detected irregularities are 
also seen in control patients without symptoms13. 
other modalities of chronic mesenteric ischemia 
diagnosis are of even lower accuracy and cannot be 
considered as significantly reproducible. treatment 
possibilities for patients with symptoms that could be 
associated with chronic mesenteric ischemia include 
surgical revascularization or percutaneous stent inser-
tions, depending on patient age, comorbidities and 
morphological characteristics of the lesion(s). Sig-
nificant difference in mortality rates and a less pro-
nounced difference in long-term success of symptom 
control depend on whether surgery was performed for 
chronic or acutized-chronic ischemia. Acutized form 
is related to worse outcomes in both categories of out-
comes14.
Due to relative shortage in prospective random-
ized controlled trials, current recommendations are 
based on sets of case series, observational studies, 
or clinical experience. management algorithms rep-
resent sound principles; however, bearing in mind 
lower evidence based grades. Therapeutic algorithms 
on acute per se or acutized chronic mesenteric isch-
emia include high index of clinical suspicion based on 
history data and typical set of symptoms or clinical 
signs. positive radiomorphological studies in addi-
tion to signs of pharmacotherapy unresponsive peri-
toneal irritation clearly indicate the earliest possible 
emergency revascularization13. Based on the associ-
ated comorbidities and common crescendo course, 
well-adjusted parenteral nutrition support in intensive 
care units seems to offer benefits over regular feed-
ing or enteral nutrition15. The possibility for amelio-
rative effects of antibiotics or probiotics in order to 
decrease bowel bacterial overgrowth and septicemia 
has not yet been systematically addressed. position 
statements about indications for revascularization in 
chronic mesenteric ischemia are not clear, as they are 
based on the unknown expected clinical course that 
might be benign versus not negligible surgery risks. 
percutaneous intervention is consistently emerging as 
a valuable parallel to surgery with comparable short- 
and long-term outcomes16. percutaneous angiographic 
interventions have recently become the first-line treat-
ment option owing to technical success rates in over 
90%, good symptom control in nearly 80% and one-
year patency rate in 85% of patients17. in angiography 
patients, the length of hospital stay is almost half that 
in surgical patients18. endovascular interventions are 
often challenged with diffuse atherosclerotic process 
unsuitable for single vessel stent implanting, risk of 
stent thrombosis, and need of surgery in case of bowel 
gangrene development. Regular diagnostic follow up 
using mSCt or color Doppler ultrasound is manda-
tory for early detection of the possible complications 
such as restenosis19. 
large bowel is the most common anatomic part of 
gastrointestinal tube affected by intestinal ischemia, 
accessible by endoscopy and showing the following 
forms of colitis: a) reversible, b) transient, c) chronic, 
d) stricture, e) gangrene, and f) fulminant pancoli-
tis13. 
primary and secondary preventive therapy mea-
sures include a variety of drug groups20. long-term 
follow up of chronic venous mesenteric thrombosis 
showed better outcomes in patients on beta blockers 
and anticoagulation therapy8. however, clear position 
and relative benefits of antiplatelet therapy, antico-
agulation, vasodilators, beta-blockers, antidiabetics 
or statins in mesenteric ischemia have not yet been 
systematically studied in prospective randomized set-
tings. 
in conclusion, chronic mesenteric ischemia fre-
quently epitomizes asymptomatic atherosclerosis. 
Convincing evidence in favor of early revasculariza-
tion strategy over primary or secondary prevention 
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with pharmaceuticals is lacking. in addition, commu-
nity prevalence of symptomatic cases is described as 
exceptionally scarce. Critical ischemia management 
by operative revascularization is as efficient as per-
cutaneous stent insertion. The perspectives of antico-
agulation and antithrombotic therapy are being inves-
tigated. Acute worsening of chronic ischemia has a 
majorly underprivileged course, hence a high index of 
clinical suspicion and early diagnosis using digital an-
giography or computerized tomography at emergency 
department are a life-saving protocol. 
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Sažetak
uSpJeŠno liJeČenJe oKluZiJe goRnJe meZenteRiČKe ARteRiJe u 86-goDiŠnJe BoleSniCe: 
pRiKAZ SluČAJA
M. Boban, B. Car, S. Schmidt, T. Krpan, T. Krčmar, D. Delić-Brkljačić, P. Brkić  i M. Vukelić
Kronična ishemija gornje mezenteričke arterije obično predstavlja klinički asimptomatsku pojavu difuznog ateroskle-
rotskog procesa. trenutno u pogledu medicine zasnovane na dokazima ne postoje jasne preporuke o korisnosti pristupa 
rane revaskularizacije prema terapiji antitrombocitnim lijekovima ili statinima. na drugoj strani, studije učestalosti uz 
dugotrajno praćenje operiranih bolesnika su kroz literaturu oskudno zastupljene. Akutizacija kronične ishemije obično 
ima vrlo ozbiljne posljedice s visokom stopom smrtnosti, pa veća klinička pozornost uza što raniju dijagnostiku i pravo-
dobnu terapijsku intervenciju predstavlja potencijalno spasonosni oblik liječenja. prikazan je slučaj 86-godišnjakinje koja 
se javila u hitnu službu zbog akutizirane aterosklerotske okluzije gornje mezenteričke arterije. Bolesnica je hitno operirana 
uz primjenu aorto-mezenteričke prstenaste proteze. poslijeoperacijski tijek bio je uredan, bez komplikacija, te je bolesnica 
povratila oko 10 kg u slijedećih nekoliko mjeseci. 
Ključne riječi: Ateroskleroza; Gornja mezenterička arterija; Ishemija crijeva; Vaskularna kirurgija; Statini; Acetilsalicilna 
kiselina

